Cefprozil
- Generic Name
- Cefprozil
- Drug Type
- Small Molecule
- Chemical Formula
- C18H19N3O5S
- CAS Number
- 92665-29-7
- Unique Ingredient Identifier
- 1M698F4H4E
- Background
Cefprozil is a cephalosporin antibiotic that is commonly employed to treat a variety of bacterial infections, including those of the ear and skin, bronchitis, and others.
- Indication
For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph
- Associated Conditions
- Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Bacterial Infections, Community Acquired Pneumonia (CAP), Streptococcal Pharyngitis, Tonsillitis streptococcal, Urinary Tract Infection, Bacterial otitis media, Uncomplicated skin and subcutaneous tissue bacterial infections
Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 35
- Registration Number
- NCT00778557
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00778739
- Locations
- 🇨🇦
Biovail Contract Research,, Toronto, Ontario, Canada
Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 27
- Registration Number
- NCT00778778
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent, Montreal, Quebec, Canada
Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 26
- Registration Number
- NCT00778245
- Locations
- 🇨🇦
MDS Pharma Services, Montreal, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.